These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 17065340)

  • 21. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans.
    Falkén Y; Webb DL; Abraham-Nordling M; Kressner U; Hellström PM; Näslund E
    Neurogastroenterol Motil; 2013 Jun; 25(6):474-80. PubMed ID: 23527561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men.
    Feltrin KL; Patterson M; Ghatei MA; Bloom SR; Meyer JH; Horowitz M; Feinle-Bisset C
    Peptides; 2006 Jul; 27(7):1638-43. PubMed ID: 16563563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin stimulates gastric emptying and hunger in normal-weight humans.
    Levin F; Edholm T; Schmidt PT; Grybäck P; Jacobsson H; Degerblad M; Höybye C; Holst JJ; Rehfeld JF; Hellström PM; Näslund E
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3296-302. PubMed ID: 16772353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
    Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man.
    Nagell CF; Pedersen JF; Holst JJ
    Scand J Gastroenterol; 2007 Jan; 42(1):28-33. PubMed ID: 17190759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
    Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
    Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.
    Abbott CR; Monteiro M; Small CJ; Sajedi A; Smith KL; Parkinson JR; Ghatei MA; Bloom SR
    Brain Res; 2005 May; 1044(1):127-31. PubMed ID: 15862798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating ghrelin levels after food intake during different phases of the migrating motor complex in man.
    Schmidt PT; Degerblad M; Lindström E; Sundqvist M; Näslund E; Gillberg PG; Husebye E; Theodorsson E; Hellström PM
    Eur J Clin Invest; 2006 Jul; 36(7):503-8. PubMed ID: 16796608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans.
    Näslund E; Bogefors J; Skogar S; Grybäck P; Jacobsson H; Holst JJ; Hellström PM
    Am J Physiol; 1999 Sep; 277(3):R910-6. PubMed ID: 10484511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered ghrelin and peptide YY responses to meals in bulimia nervosa.
    Kojima S; Nakahara T; Nagai N; Muranaga T; Tanaka M; Yasuhara D; Masuda A; Date Y; Ueno H; Nakazato M; Naruo T
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):74-8. PubMed ID: 15638873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.
    Vazquez Roque MI; Camilleri M; Stephens DA; Jensen MD; Burton DD; Baxter KL; Zinsmeister AR
    Gastroenterology; 2006 Dec; 131(6):1717-24. PubMed ID: 17087952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
    Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
    J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.
    Reidelberger R; Haver A; Anders K; Apenteng B
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E619-29. PubMed ID: 25117406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gastric emptying on the postprandial ghrelin response.
    Blom WA; Lluch A; Vinoy S; Stafleu A; van den Berg R; Holst JJ; Kok FJ; Hendriks HF
    Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E389-95. PubMed ID: 16188911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications.
    Wang L; Basa NR; Shaikh A; Luckey A; Heber D; St-Pierre DH; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G611-20. PubMed ID: 16959954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.